We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$168M
AUM Growth
+$27.9M
Cap. Flow
-$104M
Cap. Flow %
-61.85%
Top 10 Hldgs %
47.18%
Holding
44
New
7
Increased
4
Reduced
Closed
3

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$1.32M
2
ZGNX
Zogenix, Inc.
ZGNX
+$972K
3
VNDA icon
Vanda Pharmaceuticals
VNDA
+$781K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 6.85%
2 Healthcare 5.63%
3 Communication Services 4.67%
4 Financials 2.48%
5 Materials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVNA icon
1
Carvana
CVNA
$68.1B
$11.5M 6.85%
975,500
+153,000
+19% +$1.64M
GTT
2
DELISTED
GTT Communications, Inc.
GTT
$7.86M 4.67%
181,200
+59,400
+49% +$2.54M
RDNT icon
3
RadNet
RDNT
$5.03B
$5.81M 3.45%
385,996
+34,603
+10% +$494K
APO icon
4
Apollo Global Management
APO
$71.6B
$3.02M 1.79%
87,418
CPRT icon
5
Copart
CPRT
$27B
$2.32M 1.38%
+180,000
New +$2.69M
IOVA icon
6
Iovance Biotherapeutics
IOVA
$1.8B
$2.25M 1.34%
+200,000
New +$2.84M
B
7
Barrick Mining
B
$61.7B
$2.17M 1.29%
196,000
+171,000
+684% +$1.9M
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.28B
$763K 0.45%
100,000
GGAL icon
9
Galicia Financial Group
GGAL
$8.11B
$636K 0.38%
+25,000
New +$756K
PTE
10
DELISTED
PolarityTE, Inc. Common Stock
PTE
$567K 0.34%
+1,188
New +$685K
LOMA
11
Loma Negra
LOMA
$1.35B
$530K 0.31%
+60,000
New +$570K
BMA icon
12
Banco Macro
BMA
$5.95B
$517K 0.31%
+12,500
New +$671K
WATT icon
13
Energous
WATT
$78M
$101K 0.06%
+17
New +$132K
SGYP
14
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$85K 0.05%
50,000
T icon
15
AT&T
T
$159B
-54,284
Closed -$1.32M
VNDA icon
16
Vanda Pharmaceuticals
VNDA
$305M
-41,000
Closed -$781K
ZGNX
17
DELISTED
Zogenix, Inc.
ZGNX
-22,000
Closed -$972K

Similar funds

Cheyne Capital Management (UK)'s Q3 2018 Portfolio in Review

As of Q3 2018, Cheyne Capital Management (UK) held 44 positions worth $168M, up 20% from $140M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cheyne Capital Management (UK) withdrew a net $104M in Q3 2018, closing 3 positions. Its most notable exit was AT&T, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 6.9% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Cheyne Capital Management (UK) opened a new position in Iovance Biotherapeutics worth $2.25M.

  • Cheyne Capital Management (UK)'s largest Q3 2018 buy was Iovance Biotherapeutics: 200,000 shares worth $2.25M.
  • Cheyne Capital Management (UK) added most to GTT Communications, Inc. in Q3 2018, an estimated $2.54M increase.
  • Cheyne Capital Management (UK) fully exited AT&T in Q3 2018, selling an estimated $1.32M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 47% of its $168M portfolio in Q3 2018.
  • Cheyne Capital Management (UK) opened 7 new positions and closed 3 in Q3 2018.
  • Cheyne Capital Management (UK)'s portfolio value rose 20% quarter-over-quarter to $168M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q3 2018, filed 5 Nov 2018.